Programs offered by DDIC can help lead to successful approval of pharmaceutical products and NHPs. DDIC’s expertise in dosage form development, analytical testing and regulatory affairs is especially suitable for small to medium sized enterprises (SMEs) and university researchers looking to commercialize their novel drug candidates, combination products or novel dosage forms.
DDIC offers the following advantages of expertise:
- accelerated drug candidate commercialization
- early risk assessment
- development of value added products
Please visit our website for more information.
See all programs of Drug Development and Innovation Centre